Prevalence of Polycystic Kidney Disease among Medicare Beneficiaries
The trend of the percentage of adults with polycystic kidney disease among Medicare beneficiaries in the U.S. shows a mostly flat trajectory with a slight increase in 2021. Data from the Medicare 5% Sample Data indicates a low prevalence of PKD over the years. Explore the prevalence among different age groups, sexes, and races through age-standardized data and visualizations.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Prevalence of Polycystic Kidney Disease among Prevalence of Polycystic Kidney Disease among Medicare Beneficiaries Medicare Beneficiaries The trend of the percentage of adults with polycystic kidney disease is low and mostly flat with a slight increase in 2021. Data Source: Medicare 5% Sample Data https://nccd.cdc.gov/CKD/detail.aspx?Qnum=Q804
Prevalence of Polycystic Kidney Disease among U.S. Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, Overall Medicare Beneficiaries, Overall 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year
Age Age- -standardized Prevalence of Polycystic Kidney standardized Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, Overall Disease among U.S. Medicare Beneficiaries, Overall 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year
Prevalence of Polycystic Kidney Disease among Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by Age U.S. Medicare Beneficiaries, by Age 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year 65-69 years 70-79 years 80-89 years 90+ years
Prevalence of Polycystic Kidney Disease among Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by Sex U.S. Medicare Beneficiaries, by Sex 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year Male Female
Age Age- -standardized Prevalence of Polycystic Kidney standardized Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by Sex Disease among U.S. Medicare Beneficiaries, by Sex 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year Male Female
Prevalence of Polycystic Kidney Disease among Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by Race U.S. Medicare Beneficiaries, by Race 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year Non-Hispanic White Asian Non-Hispanic Black Native American Hispanic Other
Age Age- -standardized Prevalence of Polycystic Kidney standardized Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by Race Disease among U.S. Medicare Beneficiaries, by Race 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year Non-Hispanic White Asian Non-Hispanic Black Native American Hispanic Other
Prevalence of Polycystic Kidney Disease among Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by Diabetes U.S. Medicare Beneficiaries, by Diabetes 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year Without Diabetes With Diabetes
Age Age- -standardized Prevalence of Polycystic Kidney standardized Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by Diabetes Disease among U.S. Medicare Beneficiaries, by Diabetes 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year Without Diabetes With Diabetes
Prevalence of Polycystic Kidney Disease among Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by Hypertension U.S. Medicare Beneficiaries, by Hypertension 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year Without Hypertension With Hypertension
Age Age- -standardized Prevalence of Polycystic Kidney Disease standardized Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by Hypertension among U.S. Medicare Beneficiaries, by Hypertension 0.2 0.15 PKD (%) 0.1 0.05 0 2016 2017 2018 2019 2020 2021 Year Without Hypertension With Hypertension
Prevalence of Polycystic Kidney Disease among Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by CKD Stage U.S. Medicare Beneficiaries, by CKD Stage 3 2.5 2 PKD (%) 1.5 1 0.5 0 2016 2017 2018 2019 2020 2021 Year Non-CKD Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Unknown Stage
Age Age- -standardized Prevalence of Polycystic Kidney Disease standardized Prevalence of Polycystic Kidney Disease among U.S. Medicare Beneficiaries, by CKD Stage among U.S. Medicare Beneficiaries, by CKD Stage 3 2.5 2 PKD (%) 1.5 1 0.5 0 2016 2017 2018 2019 2020 2021 Year Non-CKD Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 Unknown Stage
